Reuters Health Report: September 5, 2017

Click to View in Browser Tuesday, September 5, 2017 Yemen's cholera epidemic hits 600,000 GENEVA (Reuters) - The number of people hit by cholera in Yemen since an outbreak began in April has reached 612,703, data from the World Health Organization and Yemen's health ministry showed on Tuesday. Novartis names drugs chief as CEO to deliver return to growth ZURICH (Reuters) - Novartis CEO Joe Jimenez will step down on Feb. 1 and hand over to drug development chief Vas Narasimhan to decide the fate of $50 billion in assets and make good on a pledge to return the Swiss company to sales growth. Cellectis shares slump as death puts cell therapy tests on hold LONDON (Reuters) - French cell therapy specialist Cellectis, which is developing a gene-modified cancer treatment similar to Novartis's recently approved Kymriah, has been forced to suspend testing following a patient death. Bad blood over Obamacare fight lingers as Congress returns WASHINGTON (Reuters) - When the U.S. Congress returns from summer vacation on Tuesday, for the first time in years gutting Obamacare will not be the main order of business on the healthcare agenda. Contaminated eggs found in 40 countries as EU ministers meet: DPA FRANKFURT (Reuters) - Eggs contaminated with the insecticide fipronil have been discovered in 40 countries, including 24 of the European Union's 28 member states, German news agency DPA reported on Tuesday, without citing its sources. Prostate cancer test saves lives, risks remain (Reuters Health) - Men who get a controversial blood test that looks for signs of prostate cancer appear to have a reduced risk of death from the malignancy, according to a new analysis by an international group of researchers. Heart benefit of alcohol not seen in people with liver disease (Reuters Health) - Light to moderate drinkers may have a lower risk of heart disease than teetotalers, but a new study suggests this doesn't hold true for people with fatty liver disease. German Merck considers sale of consumer health business FRANKFURT/COLOGNE (Reuters) - Germany's Merck KGaA is considering selling its $1 billion consumer health unit to meet its financial targets as a decline in its liquid crystal business forces it to review its strategy. Anthem cuts back Obamacare coverage in Missouri to 68 counties NEW YORK (Reuters) - U.S. health insurer Anthem Inc said on Friday that it will no longer offer Obamacare plans in 17 counties in Missouri but will remain in the bulk of the state, covering 68 counties that would not otherwise have Obamacare coverage for their residents. FDA approves Pfizer's leukemia drug (Reuters) - The U.S. Food and Drug Administration (FDA) on Friday approved Pfizer Inc's drug, Mylotarg, for certain patients with acute myeloid leukemia (AML), re-clearing a drug that had been pulled off the market in 2010. Related Video Neonic pesticides 'worse for bees than previously thought' Small businesses in Houston face long road to recovery A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook